In an early phase clinical trial, a combination of antibody-based medications targeting the immune system generated promising safety data and anti-tumor activity in individuals with various types of advanced cancer.
Thermo Fisher to shrink plasmid manufacturing lab in California, lay off 74 workers
Thermo Fisher is set to “adjust staffing levels” at a plasmid manufacturing laboratory in California, and the company is still exploring what to do with